Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
fda
life sciences
national blog main
national top stories
new york blog main
3
×
new york top stories
pfizer
san diego blog main
san diego top stories
akcea therapeutics
alnylam pharmaceuticals
boston
clinical trials
hereditary transthyretin amyloidosis
inotersen
nobel prize
onpattro
patisiran
rna interference
san francisco blog main
san francisco top stories
tafamidis
a2 biotherapeutics
aduro biotech
agency
akili interactive labs
alicia hager
alpha-1 antitrypsin
alzheimer's disease
amag pharmaceuticals
amgen
andrew fire
arca biopharma
arch venture partners
arrowhead pharmaceuticals
axovant gene therapies
bacteriophage
biogen
What
rnai
3
×
alnylam
drug
fda
medicine
afternoon
alliance
alnylam’s
approved
approves
bio
bristol
buy
calls
cells
changing
color
crispr
days
ema
employ
europe
follows
gene
gets
growing
harmful
history
hits
hours
interference
kudos
landmark
leaves
make
making
method
mute
myers’s
notifying
Language
unset
Current search:
rnai
×
" new york blog main "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
5 years ago
Alnylam Gets Landmark FDA OK For First-Ever RNAi Drug